STIM.NASDAQNeuronetics, INC

Form 4: Neuronetics CEO Keith J. Sullivan Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Neuronetics CEO Keith J. Sullivan sold shares of common stock on February 18th and 19th, 2025, to satisfy tax withholding obligations related to the vesting of restricted stock units.

Summary

  • Keith J. Sullivan, the President and CEO of Neuronetics, Inc., reported the sale of company stock on February 18th and 19th, 2025.
  • The sales were executed to cover tax withholding obligations arising from the vesting of restricted stock units.
  • On February 18th, 2025, 25,934 shares were sold at a weighted average price of $4.41 per share.
  • On February 19th, 2025, 24,440 shares were sold at a weighted average price of $4.70 per share.
  • Following these transactions, Sullivan directly owns 1,232,988 shares of Neuronetics common stock.
  • Sullivan has granted power of attorney to Patrick Devine, Nusrat Samjani, Stephen Furlong, W. Andrew Macan, Francis Brown, Brian Short, and Kelly Duffner to handle SEC filings related to company stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock sales to cover tax obligations, a routine financial activity.

Industry Context

Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The market typically assesses these sales in the context of the executive's overall holdings and the company's performance.

Stakeholder Impact

  • The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold compared to the total outstanding shares.
  • The sales do not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
04/01/2024Date of Power of Attorney execution by Keith J. Sullivan.
02/18/2025Sale of 25,934 shares of Common Stock at an average price of $4.41.
02/19/2025Sale of 24,440 shares of Common Stock at an average price of $4.70.
02/20/2025Date of Form 4 signature.

Keywords

Neuronetics, Keith J. Sullivan, stock sale, Form 4, SEC filing, restricted stock units, tax withholding, insider trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.